Finally looks like we are going to be making headway with the long awaited combination trial with PD1-Vaxx and Atezolizumab.
History of Changes for Study: NCT04432207
A Study of IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy, in Adults With Non-Small Cell Lung Cancer
https://clinicaltrials.gov/ct2/history/NCT04432207?A=12&B=13&C=merged#StudyPageTop
Why IMU is a multi multi bagger, page-12795
-
- There are more pages in this discussion • 12,166 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $402.5M | |||
| Open | High | Low | Value | Volume |
| 5.6¢ | 5.6¢ | 5.5¢ | $234.9K | 4.238M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 31 | 1985091 | 5.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.5¢ | 809486 | 5 |
View Market Depth
| Last trade - 10.27am 25/06/2024 (20 minute delay) ? |
| IMU (ASX) Chart |